Former Senior Vice President, Chief Operating Officer and Chief Financial Officer · IRONWOOD PHARMACEUTICALS INC (IRWD)

Sravan Emany

A named executive officer of IRONWOOD PHARMACEUTICALS in every fiscal year CompBrief holds from FY2021 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$2,968,751

Salary $575,067Stock awards $2,378,745

FY2023: $2,757,232

2nd of 5 named executive officers at Ironwood Pharmaceuticals by FY2024 total.

5 named officers on file for IRONWOOD PHARMACEUTICALS, FY2024

Sravan Emany’s pay file — $29

  • 4 fiscal years of pay, line by line
  • 10 equity grants, each cited to its filing
  • IRWD’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IRONWOOD PHARMACEUTICALS’s whole pay program stands against its peers

  • IRONWOOD PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IRWD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 28, 2025 (DEF 14A).

Free

Get Sravan Emany’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Sravan Emany compensation by year

IRONWOOD PHARMACEUTICALS Summary Compensation Table · all 4 fiscal years held
In US dollars, as IRONWOOD PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023FY2024
Salary$28,846$500,000$535,000$575,067
Bonus$200,000$0$0$0
Stock awards$2,300,100$0$1,843,347$2,378,745
Option awards$0$0$0$0
Non-equity incentive$0$198,750$361,335$0
Pension and deferred compensation$0$0$0$0
All other$46$13,612$17,550$14,938
Total$2,528,992$712,362$2,757,232$2,968,751

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IRONWOOD PHARMACEUTICALS INC DEF 14A filed April 28, 2025, accession 0001104659-25-040309, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IRONWOOD PHARMACEUTICALS INC filed document, accession 0001104659-25-040309. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2025.

$2.5M
$712K
$2.8M
$3.0M
FY21
FY22
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU116,736$1,335,460—
RSU85,000$972,400—
PSU37,118$424,630—
PSU37,117$424,618—

Per the Outstanding Equity Awards at Fiscal Year-End table in IRONWOOD PHARMACEUTICALS INC's FY2023 proxy; value at the fiscal year-end close, as the company printed it.

IRONWOOD PHARMACEUTICALS’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Thomas McCourtChief Executive Officer$6,083,631
Sravan Emany · this pageFormer Senior Vice President, Chief Operating Officer and Chief Financial Officer$2,968,751
Andrew DavisFormer Senior Vice President, Chief Business Officer$2,882,732
Michael ShetzlineSenior Vice President, Chief Medical Officer, and Head of Research and Drug Development$2,738,962
John MinardoSenior Vice President, Chief Legal Officer and Secretary$2,699,731

The full IRONWOOD PHARMACEUTICALS compensation record

free company brief

This page is one person within IRONWOOD PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IRONWOOD PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IRONWOOD PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Sravan Emany's compensation dossier · One-time report. No refunds.